Association of Systemic Inflammation Index and Body Mass Index with Survival in Patients with Renal Cell Cancer Treated with NivolumabUgo De Giorgi, Cora N. Sternberg, Giuseppe Procopio et al.|Clinical Cancer Research|2019Cited by 240
Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOXJean‐François Emile, Yves Humblet, Stéphanie Dimet et al.|European Journal of Cancer|2017Cited by 47
Inflammatory indexes strongly predict clinical outcome in patients (pts) with metastatic renal cell cancer (mRCC) treated with nivolumab: results from the Italian expanded access program (EAP)Ugo De Giorgi, Cora N. Sternberg, Giuseppe Procopio et al.|Annals of Oncology|2017Cited by 3
Association of body mass index and systemic inflammation index with survival in patients with renal cell cancer treated with nivolumab.Ugo De Giorgi, Cora N. Sternberg, Giuseppe Procopio et al.|Journal of Clinical Oncology|2019Cited by 2